FDA Should Be Allowed To Schedule Foreign Inspections Based On Risk – CDER’s Woodcock
This article was originally published in The Pink Sheet Daily
Executive Summary
“Risk-based” may be code for doing the minimum because of underfunding, Rep. Dingell says.
You may also be interested in...
FDA Wants Authority To Enforce Track-And-Trace System For Drugs
Congress should empower FDA to enforce the track-and-trace standard for drugs that the agency already is tasked with developing, Deputy Commissioner for Global Regulatory Operations and Policy Deborah Autor told the Senate Health, Education, Labor and Pensions Committee Sept. 14.
FDA Wants Authority To Enforce Track-And-Trace System For Drugs
Congress should empower FDA to enforce the track-and-trace standard for drugs that the agency already is tasked with developing, Deputy Commissioner for Global Regulatory Operations and Policy Deborah Autor told the Senate Health, Education, Labor and Pensions Committee Sept. 14.
Latest Draft Of Rep. Dingell’s Global Drug Safety Bill Would Exempt Small Firms From Inspection Fees
FDA would have flexibility to set inspection schedules; committee may use bill to address FDA executive bonuses